Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results| (NASDAQ: CRVS) | Delayed: 11.91 -0.09 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $17.77 | |||
| Open | $12.36 | 52 Week Low | $9.63 | |||
| Day High | $12.58 | P/E | N/A | |||
| Day Low | $11.73 | EPS | $0.00 | |||
| Volume | 1,977,182 | |||||

